| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
110.25(B) |
| Last
Volume: |
6,013,077 |
Avg
Vol: |
8,376,873 |
| 52
Week Range: |
$48.64 - $77.42 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
304,513 |
503,645 |
996,293 |
2,118,674 |
| Total Sell Value |
$22,679,618 |
$34,760,114 |
$60,765,476 |
$110,963,213 |
| Total People Sold |
9 |
10 |
11 |
13 |
| Total Sell Transactions |
14 |
26 |
43 |
79 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$5,742 |
D/D |
(777) |
30,465 |
|
- |
|
| Fitzgerald Joseph Michael |
SVP & President, Endovascular |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,996 |
31,242 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$8,402 |
D/D |
(1,137) |
21,177 |
|
- |
|
| Moreci Stephen F |
SVP, Global Sales Operations |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,995 |
22,314 |
|
- |
|
| Colen Fred |
EVP & Chief Technology Officer |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$48,966 |
D/D |
(6,626) |
62,815 |
|
- |
|
| Colen Fred |
EVP & Chief Technology Officer |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,468 |
69,441 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$19,310 |
D/D |
(2,613) |
42,366 |
|
- |
|
| Kucheman William |
EVP, Cardiology |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,986 |
44,979 |
|
- |
|
| Gilbert James |
EVP, Strategy & Business Dev |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$11,203 |
D/D |
(1,516) |
65,393 |
|
- |
|
| Gilbert James |
EVP, Strategy & Business Dev |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,993 |
66,909 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$30,927 |
D/D |
(4,185) |
59,485 |
|
- |
|
| Pucel Kenneth |
EVP, Global Operations |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,178 |
63,670 |
|
- |
|
| Lance Jean Fitterer |
Chief Compliance Officer |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$9,186 |
D/D |
(1,243) |
50,068 |
|
- |
|
| Lance Jean Fitterer |
Chief Compliance Officer |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,194 |
51,311 |
|
- |
|
| Mcfaul David W |
SVP, International |
• – – |
2010-02-12 |
4 |
D |
$7.39 |
$7,841 |
D/D |
(1,061) |
41,426 |
|
- |
|
| Mcfaul David W |
SVP, International |
• – – |
2010-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,795 |
42,487 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(119,722) |
16,172,921 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(102,016) |
10,356,021 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(113,052) |
16,292,643 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(90,889) |
10,458,037 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(101,721) |
16,405,695 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-22 |
4 |
D |
$0.00 |
$0 |
I/I |
(89,068) |
10,548,926 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(99,805) |
16,507,416 |
|
- |
|
| Nicholas Peter M |
Director |
– • – |
2010-01-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(86,080) |
10,637,994 |
|
- |
|
| Abele John E |
Director |
– • – |
2010-01-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,946) |
16,607,221 |
|
- |
|
2009 Records found
|
|
Page 54 of 81 |
|
|
0.41 (0.53%) 
